154 participants
Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-26
- Start Date:
- 2026-08-20
- Completion:
- 2027-12-31
Conditions
- Biliary Tract Cancer (BTC)
Interventions
- DRUG
No Results Yet